Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)

Oct 15, 2026

October 15 FDA Update Confirms Minor Labeling Changes Ahead of November 10 Goal Date, While an $11.18 Million DARPA Contract and Innovative Depression Research Expand the Company's Potential

MIAMI - Oct. 15, 2026 - PRLog -- NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP is approaching a pivotal period in its development, with a new FDA update putting its preservative-free ketamine program firmly in focus. On October 15, 2026, the company announced that the U.S. Food and Drug Administration had issued a Discipline Review Letter requesting minor changes to the product's submitted labeling. The FDA also requested sample labeling incorporating the proposed proprietary product name, which remains under review, ahead of the application's November 10, 2026, goal date. Importantly, NRx reported that all requested labeling changes were classified as minor, while final manufacturing process validation runs are underway to support potential commercialization. The announcement provides investors with a defined upcoming regulatory milestone and adds to a broader corporate story encompassing pharmaceutical development, advanced brain stimulation technology, and government-funded clinical research. <Cite refs={["turn117971news13","turn117971search7"]}/>

FDA Update Places November 10 in the Spotlight

NRx's latest announcement marks another important step in its efforts to bring preservative-free intravenous ketamine to the U.S. market through an Abbreviated New Drug Application (ANDA). Ketamine is an established medicine used in clinical settings, and NRx has emphasized the potential value of a preservative-free preparation amid concerns about hospital supply reliability.

The FDA's October 15 letter requests minor labeling revisions and sample labels featuring the proposed product name. This follows the agency's September 15 decision to reclassify an earlier application amendment related to the drug vial from a major amendment to a minor amendment, setting the November 10 GDUFA goal date.

For investors, several developments stand out:
  • Minor labeling requests: The company reports that all changes requested in the latest letter were classified as minor.
  • November 10 goal date: This remains the announced FDA review milestone for the ANDA.
  • Manufacturing readiness: NRx says final manufacturing process validation runs are underway.
  • Product-name review: The proposed proprietary name remains under FDA review.

The distinction between progress and approval remains essential. The latest communication does not constitute FDA approval, and the agency's final decision remains pending. Nevertheless, the combination of a defined review date, remaining labeling work, and manufacturing preparation provides a concrete set of milestones for investors to follow. <Cite refs={["turn117971news13","turn117971search7"]}/>

An $11.18 Million DARPA Contract Adds a Major Research Catalyst

NRx's development strategy extends well beyond its immediate ketamine opportunity. On September 30, 2026, its subsidiary NRx Defense Systems announced an approximately $11.18 million prime contract from the Defense Advanced Research Projects Agency (DARPA) to evaluate SPARC-TMS, a clinical research program combining robotic, neuronavigated transcranial magnetic stimulation (TMS) with NRX-101, NRx's investigational oral drug candidate.

The trial is designed to evaluate whether a single-day treatment protocol can help patients with treatment-resistant depression. It brings together NRx Defense Systems, HOPE Therapeutics, McLean Hospital, Arizona State University, Zeta Surgical Systems, and Neurocare of America.

The contract has an 18-month performance period. Approximately $6.7 million was initially obligated, with additional funding dependent on appropriations and the exercise of contract options. Payments are tied to program milestones.

This arrangement offers an important opportunity to advance research while supporting a potentially differentiated treatment approach. If the trial produces encouraging results, it could help establish a foundation for further development of NRX-101 alongside TMS. The clinical results, however, will determine whether the approach can support subsequent regulatory applications.

HOPE Therapeutics Connects Research With Advanced Treatment Technology

NRx's subsidiary HOPE Therapeutics is another important part of the company's strategy. On September 11, NRx announced that HOPE was preparing to deploy Zeta Surgical's FDA-cleared robotic TMS navigation system at its Florida clinics.

The technology is designed to help clinicians position TMS equipment using advanced navigation software. Its potential role in delivering consistent treatment positioning complements the company's interest in combining pharmaceutical candidates with technology-enabled psychiatric care.

This creates a connection between NRx's research pipeline and an operating clinical network. HOPE's facilities may provide experience with advanced treatment delivery and a platform for participating in clinical programs, subject to the applicable study requirements.

Together, the robotic TMS initiative and SPARC-TMS contract give investors another area to monitor as NRx works to develop differentiated approaches for difficult-to-treat depression. <Cite refs={["turn117971search9","turn117971search10"]}/>

NRX-100 and NRX-101 Anchor the Pharmaceutical Pipeline

NRx's two principal drug-development programs address different opportunities.

NRX-100 is the company's preservative-free intravenous ketamine product. In addition to its ANDA, NRx has initiated a separate New Drug Application pathway for potential use in treating suicidal ideation in patients with depression, including bipolar depression. The company has reported FDA Fast Track Designation for this development program.

NRX-101 is an investigational oral combination of D-cycloserine and lurasidone. NRx has pursued its development for serious depression-related conditions, including suicidal bipolar depression, and has reported FDA Breakthrough Therapy Designation for that indication.

These programs offer different potential catalysts and follow distinct regulatory pathways. The near-term focus is the preservative-free ketamine ANDA, while the broader pipeline provides additional opportunities for clinical and regulatory progress.

The SPARC-TMS program is particularly notable because it could explore NRX-101 in combination with robotic brain stimulation for treatment-resistant depression, potentially opening a separate avenue for future development if supported by clinical evidence. <Cite refs={["turn117971news13","turn117971search9"]}/>

Manufacturing Preparation and Financial Resources

NRx has previously reported commercial-scale manufacturing preparations for preservative-free ketamine, including plans to build launch inventory. In its August 17, 2026, second-quarter update, the company described plans for approximately five million doses of launch inventory and additional production following a potential launch.

The company also reported completing an underwritten public offering that generated approximately $22.3 million in gross proceeds. On June 30, 2026, NRx reported approximately $26.7 million in cash and cash equivalents and stated that its resources were expected to support at least one year of operations.

These earlier disclosures provide useful context as the company approaches its next regulatory milestone. Manufacturing validation, cash utilization, additional financing needs, and commercial execution will all be important considerations if approval is obtained. The reported financial position reflects the company's position at the end of the second quarter, rather than a guarantee of its current cash balance or future funding requirements. <Cite refs={["turn117971search10"]}/>

Key NRXP Developments to Watch
  • October 15, 2026: FDA requests minor labeling changes for preservative-free ketamine.
  • November 10, 2026: Announced GDUFA goal date for the ketamine ANDA.
  • Manufacturing: Final process validation runs are underway, according to the company.
  • DARPA contract: Approximately $11.18 million awarded for the SPARC-TMS research program.
  • HOPE Therapeutics: Continued development of robotic TMS capabilities.
  • NRX-101: Ongoing development of an investigational treatment for serious depression-related conditions.

The Bottom Line: A Significant Period for NRx Pharmaceuticals

NRx Pharmaceuticals is advancing several interconnected opportunities in neuroscience and mental health, with the preservative-free ketamine review serving as its most immediate regulatory catalyst.

Today's FDA announcement provides a clearer view of the remaining labeling work ahead of the November 10 goal date. At the same time, the DARPA-funded SPARC-TMS program, HOPE Therapeutics' technology initiatives, and the broader NRX-100 and NRX-101 pipeline give investors additional developments to follow.

For more information on $NRXP visit: https://www.nrxpharma.com and https://compasslivemedia.com/case-study/nrx-pharmaceuticals/

Media Contact
Company Name: NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
Contact Person: Brian Korb, Managing Partner, astr partners
Email: [email protected]
Phone: (917) 653-5122
Country: United States

DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website

Contact
CorporateAds
***@gmail.com

Photos: (Click photo to enlarge)




Source: CorporateAds

Read Full Story - Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP) | More news from this source

Press release distribution by PRLog
MORE NEWS
SK, Samsung among Korean firms considering Westinghouse stake acquisition
Oct 15, 2026
SK, Samsung among Korean firms considering Westinghouse stake acquisition

Major Korean companies including Samsung, SK and Doosan are considering participating in the acquisition of a stake in U.S. nuclear power company Westinghouse, according to industry sources. If private companies join nuclear cooperation between Korea and the United States, which has so far been led largely by state-run companies such as Korea Electric Power Corp. (KEPCO) and Korea Hydro & Nuclear Power (KHNP), the move is expected to give Korean companies greater momentum in entering the U.S. nuclear power market. Government and industry sources said Wednesday that the government has been surveying nuclear power-related companies about their interest in investing in Westinghouse since announcing its investment plans in the United States. Companies interested in participating recently gathered at a meeting hosted by KEPCO to discuss potential investment options, according to the sources. Samsung C&T, SK Group, Hyundai Engineering & Construction and Doosan Enerbility were among the companies that attended the meeting. Securing a stake in Westinghouse is one of the key issues in investment

Taihan Cable & Solution wins large US power grid turnkey project
Oct 15, 2026
Taihan Cable & Solution wins large US power grid turnkey project

Taihan Cable & Solution, a leading power cable and energy infrastructure manufacturer, said Thursday that its U.S. subsidiary has won a turnkey extra-high-voltage grid project in the United States, capitalizing on surging power demand from artificial intelligence (AI) and data centers. Under the deal, the subsidiary, T.E.USA, will oversee local engineering, construction and other work, while the Korean headquarters will produce and supply key materials such as extra-high-voltage cables and joints. In a turnkey contract, a single company handles a project from design through construction and hands it over ready for operation. The headquarters and the U.S. unit signed a material supply contract worth about 120 billion won ($89 million), which the company disclosed in a regulatory filing Thursday. Taihan did not reveal the total value of the turnkey project or the client, citing a nondisclosure agreement. The order follows another extra-high-voltage turnkey project worth about 100 billion won that the company won in the U.S. in January. Taihan said it has won all 500-kilovolt high-voltage a

CJ ONE launches global membership service for foreign visitors
Oct 15, 2026
CJ ONE launches global membership service for foreign visitors

CJ OliveNetworks, the digital and technology unit of CJ Group, is branching into the travel industry with a new global membership service that enables foreign visitors in Korea to earn rewards and redeem points at participating merchants, leveraging the country's tourism boom to drive new growth. The company said Thursday that its lifestyle membership platform, CJ ONE, had introduced CJ ONE Global, allowing international visitors to sign up using only email verification, without requiring a Korean phone number or domestic identification. The launch comes as interest in Korean food, shopping and culture spreads alongside the global popularity of Korean entertainment. According to the Korea Tourism Organization, about 12.8 million foreign tourists visited Korea from January through July, up 21.3 percent from the same period last year. Once registered, members receive a mobile barcode through the CJ ONE app that they can use to earn and redeem points at participating stores, as well as access new-member and birthday benefits. The service connects visitors with businesses spanning tourism, re

FADU unveils world's 1st file-semantic SSD to power AI workloads
Oct 15, 2026
FADU unveils world's 1st file-semantic SSD to power AI workloads

Korean data center chipmaker FADU has unveiled what it calls the world’s first file-semantic solid-state drive (SSD), a storage technology designed to help artificial intelligence (AI) systems access data faster while reducing computing overhead and power consumption. The company introduced its file-semantic SSD, or FS-SSD, at the 2026 Open Compute Project Global Summit in San Jose, California, which ran from Monday to Thursday under the theme “Scaling Innovation for the AI Era.” Unlike conventional SSDs, which manage data through block addresses, FADU’s FS-SSD is designed to recognize and manage files directly, shifting tasks traditionally handled by a server’s central processing unit and operating system into the storage device itself. The technology uses FADU’s sixth-generation SSD controller, equipped with firmware that handles file searches, access permissions and file-to-address translation within the drive. By embedding file requests in standard Non-Volatile Memory Express commands, the system allows accelerators such as graphics processing units and data processing un

Korean, US biz leaders call for support to accelerate Korean investment projects in US
Oct 15, 2026
Korean, US biz leaders call for support to accelerate Korean investment projects in US

Korean and U.S. business leaders on Thursday called for faster regulatory approvals, tax and financial support, and visa reforms to ensure the successful implementation of major Korean investment projects in the United States. The call came in a joint declaration issued at a plenary meeting of the U.S.-Korea and Korea-U.S. Business Council, hosted by the Federation of Korean Industries (FKI), and attended by about 60 political and business leaders and experts from the two countries. Earlier this month, U.S. President Donald Trump announced details of Seoul's planned $200 billion investment in the U.S., part of a broader $350 billion commitment agreed to by the two countries last year in exchange for lower U.S. tariffs on Korean goods. In the joint declaration, the business circles called for measures to reduce trade uncertainty and reform regulations, urging the two governments to introduce fast-track approval procedures and provide tax and financial incentives for companies participating in strategic investment projects. They also called for improvements to visa systems and the establis

Filipinos rank among top 3 AI users on messaging platform
Oct 15, 2026
Filipinos rank among top 3 AI users on messaging platform

Filipinos rank among the top three markets worldwide for artificial intelligence feature usage on Rakuten Viber, according to the messaging platform, with young professionals among the most active users of its AI tools. Viber Chief Product Officer Nadav Melnick said nearly 20% of the platform’s monthly active AI users in the Philippines are aged 25

MIDEA kicks off Xpress Hub tour with space and money saving appliances
Oct 15, 2026
MIDEA kicks off Xpress Hub tour with space and money saving appliances

Written by INQUIRER.net Tech Editor Jayvee Fernandez for Midea As a southie, I really make it a point to make my trips up north worth the drive. After discovering the MIDEA Xpress Hub was unveiling its new product line at Waltermart in North EDSA, I had to see for myself what new things MIDEA had

Alibaba sets sights on record-breaking Singles’ Day with 1 million brands joining festival
Oct 15, 2026
Alibaba sets sights on record-breaking Singles’ Day with 1 million brands joining festival

Alibaba Group Holding is gearing up for its annual Singles’ Day shopping festival on major online marketplaces Taobao and Tmall, with the company expecting a record one million global brands to take part this year. Pre-sales for the event open on Thursday, followed by the formal sale next Tuesday. The company projects more than 70 million products to feature, also a record for the festival. Created by Alibaba in 2009, Singles’ Day has grown into the world’s largest online shopping festival. Also...

DeepSeek offers user refunds after suffering another major outage
Oct 15, 2026
DeepSeek offers user refunds after suffering another major outage

Chinese artificial intelligence firm DeepSeek apologised and promised compensation to users after its services suffered a nearly five-hour outage on Thursday. DeepSeek will issue users a full refund for any consumption between October 8 and October 14 in the form of credits, according to a notice posted on the Hangzhou-based start-up’s application programming interface (API) platform. DeepSeek’s namesake chatbot and API services for its V4 Pro and V4.1 Flash models went offline on Thursday...

Tillis calls on Pentagon inspector general to investigate Ukraine’s Starshield loss
Oct 15, 2026
Tillis calls on Pentagon inspector general to investigate Ukraine’s Starshield loss

Sen. Thom Tillis (R-N.C.) says he and his Senate colleagues will ask the Defense Department’s inspector general to investigate Ukraine’s sudden loss of access to the military version of Starlink, known as Starshield, which hampered Ukraine’s ability to intercept Russian drones. Tillis said the “snafu” that left Ukrainian civilian and military targets exposed now appears...

Z.ai’s GLM-5.3 raises researcher fears the Chinese model can fake AI safety tests
Oct 15, 2026
Z.ai’s GLM-5.3 raises researcher fears the Chinese model can fake AI safety tests

Chinese artificial intelligence lab Z.ai’s latest flagship model, GLM-5.3, may be sophisticated enough to “fake” its way through safety tests, according to a new report published Thursday, sparking new fears about the ability of artificial intelligence systems to shape their own development. The model, launched in August, showed an ability to consider how its behaviour during safety evaluations might influence how future versions of itself would be trained, according to AI safety organisation...

TSMC confirms talks with Elon Musk over Texas ‘Terafab’ but insists on operational control
Oct 15, 2026
TSMC confirms talks with Elon Musk over Texas ‘Terafab’ but insists on operational control

Taiwan Semiconductor Manufacturing Co (TSMC) is in discussions regarding a potential role in Elon Musk’s proposed Terafab project in Texas, according to company chairman and CEO C.C. Wei, although he stressed that TSMC would retain operational control of any partner factory. The plant “has got to be run by TSMC”, Wei said during the third-quarter earnings call on Thursday. TSMC, the world’s largest contract chipmaker, has sent teams to Texas to assess expansion opportunities beyond its US hub in...

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Always dynamic, always updated, The Witness Daily ensures minute-by-minute update to the most pressing issues, curated specifically to cater to critical newsreaders of our time.

Copyright © 2015 - 2026 Redshift Daily. All Rights Reserved.